
Mr Michael Whitlow is an entrepreneur and investor with over 20 years’ experience across small-cap and early-stage companies in multiple sectors and jurisdictions.

Mr Nicholas Tulloch has advised companies on the UK capital markets for over 20 years, working for several well-known investment banks and stockbrokers, including Cazenove, Arbuthnot and Cenkos.

Dr Peter Sargent brings over 18 years of experience working within the life sciences sector, with extensive commercial, scientific and operational expertise across drug and diagnostic development.

Mr Ian Bagnall is a Chartered Accountant with over three decades of experience across corporate finance, operational leadership and investment management. He also holds a BSc in Biochemistry and Physiology.

Hayley Close joins Physiomics with 5 years business development experience.

Jesse Thissen is an experienced statistician with a background in large pharma (AstraZeneca) as well as Biotech, FMCG and CRO companies.

Dr Mark Davies brings over 20 years’ experience in drug development.

Dr Frances Brightman is a computational biology specialist with over 21 years experience.

Léa Sta is an applied mathematician with experience in cell signalling and receptor-ligand models.

Ghaith is a pharmacokinetics and pharmacodynamics (PK/PD) modelling specialist with experience in both industry and academic environments.

Charmaine Fraser brings with her a wealth of Administrative and Managerial experience.

Dr Hitesh Mistry, is a modelling and simulation specialist within the pharmaceutical industry.

Dr Misba Beerahee PhD has over four decades of pharmaceutical development experience as a clinical pharmacologist.

Dr Michael Ghebre, has extensive experience working across academia and industry, and CRO companies as a statistician.

Dr Claire Villette is a biomedical computational scientist with 9 years experience.

Dr Christophe Chassagnole has led systems biology and bio-computing projects for over 20 years.